The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Specialization of tumour vasculature
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Giancotti, F. G., & Ruoslahti, E. (1999) · Science · doi:10.1126/science.285.5430.1028 · Cited by 3,869
Requirement of Vascular Integrin α v β 3 for Angiogenesis
Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D., & Wiegand, S. J. (1999) · Science · doi:10.1126/science.284.5422.1994 · Cited by 2,195
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054
Self-citationVascular Channel Formation by Human Melanoma Cells in Vivo and in Vitro: Vasculogenic Mimicry
Maniotis, A. J., Folberg, R., Hess, A., Seftor, E. A., Gardner, L. M. G., Pe'er, J., Trent, J. M., Meltzer, P. S., & Hendrix, M. J. C. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65173-5 · Cited by 2,043
Genes Expressed in Human Tumor Endothelium
Croix, B. S., Rago, C., Velculescu, V., Traverso, G., Romans, K. E., Montgomery, E., Lal, A., Riggins, G. J., Lengauer, C., Vogelstein, B., et al. (2000) · Science · doi:10.1126/science.289.5482.1197 · Cited by 1,845
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., & Detmar, M. (2001) · Nature Medicine · doi:10.1038/84643 · Cited by 1,733
Openings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
Definition of Two Angiogenic Pathways by Distinct α v Integrins
Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A., & Cheresh, D. A. (1995) · Science · doi:10.1126/science.270.5241.1500 · Cited by 1,321
VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
Stacker, S. A., Caesar, C., Baldwin, M. E., Thornton, G. E., Williams, R. A., Prevo, R., Jackson, D. G., Nishikawa, S.-I., Kubo, H., & Achen, M. G. (2001) · Nature Medicine · doi:10.1038/84635 · Cited by 1,246
Lack of Pericytes Leads to Endothelial Hyperplasia and Abnormal Vascular Morphogenesis
Hellström, M., Gerhardt, H., Kalén, M., Li, X., Eriksson, U., Wolburg, H., & Betsholtz, C. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.3.543 · Cited by 1,100
Angiosarcomas Express Mixed Endothelial Phenotypes of Blood and Lymphatic Capillaries
Breiteneder-Geleff, S., Soleiman, A., Kowalski, H., Horvat, R., Amann, G., Kriehuber, E., Diem, K., Weninger, W., Tschachler, E., Alitalo, K., et al. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65285-6 · Cited by 1,090
Clinical applications of angiogenic growth factors and their inhibitors
Ferrara, N., & Alitalo, K. (1999) · Nature Medicine · doi:10.1038/70928 · Cited by 1,004
Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
Mandriota, S. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.4.672 · Cited by 978
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R., Shapiro, L., Arap, W., & Ruoslahti, E. I. (2000) · PubMed · Cited by 966
Self-citationAnti-cancer activity of targeted pro-apoptotic peptides
Ellerby, H. M., Arap, W., Ellerby, L. M., Kain, R., Andrusiak, R., Rio, G. D., Krajewski, S., Lombardo, C. R., Rao, R., Ruoslahti, E., et al. (1999) · Nature Medicine · doi:10.1038/12469 · Cited by 936
Self-citationRegulation of angiogenesis via vascular endothelial growth factor receptors.
Veikkola, T., Karkkainen, M. J., Claesson, L., & Alitalo, K. K. (2000) · PubMed · Cited by 864
Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging
Sipkins, D. A., Cheresh, D. A., Kazemi, M. R., Nevin, L. M., Bednarski, M. D., & Li, K. C. P. (1998) · Nature Medicine · doi:10.1038/nm0598-623 · Cited by 850
Makinen, T. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4762 · Cited by 845
Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.
Brooks, P. C., Strömblad, S., Klemke, R., Visscher, D., Sarkar, F. H., & Cheresh, D. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118227 · Cited by 828
The Adaptor Protein Shc Couples a Class of Integrins to the Control of Cell Cycle Progression
Wary, K. K., Mainiero, F., Isakoff, S. J., Marcantonio, E. E., & Giancotti, F. G. (1996) · Cell · doi:10.1016/s0092-8674(00)81392-6 · Cited by 731
Gerety, S. S., Wang, H. U., Chen, Z.-F., & Anderson, D. J. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80342-1 · Cited by 707
Embryonic mesodermal defects in α5 integrin-deficient mice
Yang, J. T., Rayburn, H., & Hynes, R. O. (1993) · Development · doi:10.1242/dev.119.4.1093 · Cited by 691
Vasculogenic Mimicry and Tumor Angiogenesis
Folberg, R., Hendrix, M. J. C., & Maniotis, A. J. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64739-6 · Cited by 684
Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood
Chang, Y. S., di Tomaso, E., McDonald, D. M., Jones, R., Jain, R. K., & Munn, L. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14608 · Cited by 671
Eliceiri, B. P., & Cheresh, D. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6869 · Cited by 649
Bader, B. L., Rayburn, H., Crowley, D., & Hynes, R. O. (1998) · Cell · doi:10.1016/s0092-8674(00)81618-9 · Cited by 647
Kim, S., Bell, K., Mousa, S. A., & Varner, J. A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65005-5 · Cited by 635
Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor-2
Soldi, R., Mitola, S., Strasly, M., Defilippi, P., Tarone, G., & Bussolino, F. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.882 · Cited by 626
Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins
Reynolds, L. E., Wyder, L., Lively, J. C., Taverna, D., Robinson, S. D., Huang, X., Sheppard, D., Hynes, R. O., & Hodivala-Dilke, K. M. (2002) · Nature Medicine · doi:10.1038/nm0102-27 · Cited by 613
NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis
Ozerdem, U., Grako, K. A., Dahlin‐Huppe, K., Monosov, E., & Stallcup, W. B. (2001) · Developmental Dynamics · doi:10.1002/dvdy.1200 · Cited by 593
Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins
Stupack, D. G., Puente, X. S., Boutsaboualoy, S., Storgard, C. M., & Cheresh, D. A. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200106070 · Cited by 554
VEGFR-3 and Its Ligand VEGF-C Are Associated with Angiogenesis in Breast Cancer
Valtola, R., Salven, P., Heikkilä, P., Taipale, J., Joensuu, H., Rehn, M., Pihlajaniemi, T., Weich, H., deWaal, R., & Alitalo, K. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65392-8 · Cited by 541
Contrino, J., Hair, G., Kreutzer, D. L., & Rickles, F. R. (1996) · Nature Medicine · doi:10.1038/nm0296-209 · Cited by 539
Senger, D. R., Claffey, K. P., Benes, J. E., Perruzzi, C. A., Sergiou, A. P., & Detmar, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13612 · Cited by 522
Plate, K. H., Breier, G., Millauer, B., Ullrich, A., & Risau, W. (1993) · PubMed · Cited by 498
(2000) · PubMed · Cited by 475
Hendrix, M. J. C., Seftor, E. A., Meltzer, P. S., Gardner, L. M. G., Hess, A. R., Kirschmann, D. A., Schatteman, G. C., & Seftor, R. E. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131209798 · Cited by 456
Carreira, C. M., Nasser, S. M., di Tomaso, E., Padera, T. P., Boucher, Y., Tomarev, S. I., & Jain, R. K. (2001) · PubMed · Cited by 444
Kerbel, R. S. (1991) · BioEssays · doi:10.1002/bies.950130106 · Cited by 441
A Mechanism for Modulation of Cellular Responses to VEGF Activation of the Integrins
Byzova, T. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00083-6 · Cited by 438
Curnis, F., Sacchi, A., Borgna, L., Magni, F., Gasparri, A., & Corti, A. (2000) · Nature Biotechnology · doi:10.1038/81183 · Cited by 419
Lymphangiogenesis and tumor metastasis: myth or reality?
Pepper, M. S. (2001) · PubMed · Cited by 418
Cell surface tumor endothelial markers are conserved in mice and humans.
Carson-Walter, E. B., Watkins, D. N., Nanda, A., Vogelstein, B., Kinzler, K. W., & Croix, B. S. (2001) · PubMed · Cited by 414
Pozzi, A., Moberg, P. E., Miles, L. A., Wagner, S., Soloway, P., & Gardner, H. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040378497 · Cited by 395
The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization
Ogawa, K., Pasqualini, R., Lindberg, R. A., Kain, R., Freeman, A. L., & Pasquale, E. B. (2000) · Oncogene · doi:10.1038/sj.onc.1204004 · Cited by 380
Seftor, R. E. B., Seftor, E. A., Koshikawa, N., Meltzer, P. S., Gardner, L. M. G., Bilban, M., Stetler‐Stevenson, W. G., Quaranta, V., & Hendrix, M. J. C. (2001) · PubMed · Cited by 369
Role of B61, the Ligand for the Eck Receptor Tyrosine Kinase, in TNF-α-Induced Angiogenesis
Pandey, A., Shao, H., Marks, R. M., Polverini, P. J., & Dixit, V. M. (1995) · Science · doi:10.1126/science.7536959 · Cited by 363
Gale, N. W., Baluk, P., Pan, L., Kwan, M., Holash, J., DeChiara, T. M., McDonald, D. M., & Yancopoulos, G. D. (2001) · Developmental Biology · doi:10.1006/dbio.2000.0112 · Cited by 363
LYVE-1, the lymphatic system and tumor lymphangiogenesis
Jackson, D. G., Prevo, R., Clasper, S., & Banerji, S. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01936-6 · Cited by 350
CD13/APN is activated by angiogenic signals and is essential for capillary tube formation
Bhagwat, S. V., Lahdenranta, J., Giordano, R., Arap, W., Pasqualini, R., & Shapiro, L. H. (2001) · Blood · doi:10.1182/blood.v97.3.652 · Cited by 334
The fibronectin isoform containing the ed‐b oncofetal domain: A marker of angiogenesis
Castellani, P., Viale, G., Dorcaratto, A., Nicolo, G., Kaczmarek, J., Querze, G., & Zardi, L. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910590507 · Cited by 316
Shin, D., Garcia-Cardena, G., Hayashi, S.-I., Gerety, S., Asahara, T., Stavrakis, G., Isner, J., Folkman, J., Gimbrone, M. A., & Anderson, D. J. (2001) · Developmental Biology · doi:10.1006/dbio.2000.9957 · Cited by 307
Borges, E., Jan, Y., & Ruoslahti, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007040200 · Cited by 293
Self-citationDelivery of molecular and cellular medicine to solid tumors
Jain, R. K. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00027-6 · Cited by 271
Silletti, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011343298 · Cited by 262
Trophoblast pseudo-vasculogenesis: faking it with endothelial adhesion receptors
Damsky, C. H., & Fisher, S. J. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80043-4 · Cited by 248
A Signaling Pathway from the α5β1 and αvβ3 Integrins That Elevatesbcl-2 Transcription
Matter, M. L., & Ruoslahti, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102014200 · Cited by 244
Self-citationHess, A. R., Seftor, E. A., Gardner, L. M., Carles‐Kinch, K., Schneider, G. B., Seftor, R. E. B., Kinch, M. S., & Hendrix, M. J. C. (2001) · PubMed · Cited by 240
A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis
Yi, M., & Ruoslahti, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.620 · Cited by 232
Self-citationSchlingemann, R. O., Rietveld, F. J. R., de Waal, R. M. W., Ferrone, S., & Ruiter, D. J. (1990) · Europe PMC (PubMed Central) · Cited by 224
Nilsson, F., Kosmehl, H., Zardi, L., & Neri, D. (2001) · PubMed · Cited by 212
Delivery of Molecular and Cellular Medicine to Solid Tumors
Jain, R. K. (1997) · Microcirculation · doi:10.3109/10739689709148314 · Cited by 198
Vasculogenic Mimicry: How Convincing, How Novel, and How Significant?
McDonald, D. M., Munn, L., & Jain, R. K. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64740-2 · Cited by 187
NG2 proteoglycan-binding peptides target tumor neovasculature.
Burg, M. A., Pasqualini, R., Arap, W., Ruoslahti, E. I., & Stallcup, W. B. (1999) · PubMed · Cited by 166
Self-citationTargeting tumor vasculature with homing peptides from phage display
Ruoslahti, E. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0334 · Cited by 157
Self-citationSolution Structures and Integrin Binding Activities of an RGD Peptide with Two Isomers
Assa‐Munt, N., Jia, X., Laakkonen, P. M., & Ruoslahti, E. I. (2001) · Biochemistry · doi:10.1021/bi002101f · Cited by 157
Self-citationErdreich‐Epstein, A., Shimada, H., Groshen, S. G., Liu, M., Metelitsa, L. S., Kim, K., Stins, M. F., Seeger, R. C., & Durden, D. L. (2000) · PubMed · Cited by 148
Human endothelial cells express integrin receptors on the luminal aspect of their membrane
Conforti, G., Domı́nguez-Jiménez, C., Zanetti, A., Gimbrone, M. J., Cremona, O., Marchisio, P., & Dejana, E. (1992) · Blood · doi:10.1182/blood.v80.2.437.437 · Cited by 136
Hu, Z., & Garen, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201420298 · Cited by 110
Schrappe, M., Klier, F. G., Spiro, R. C., Waltz, T. A., Reisfeld, R., & Gladson, C. L. (1991) · PubMed · Cited by 106
Steitz, J., Br�ck, J., Steinbrink, K., Enk, A., Knop, J. X. F. R., & Tüting, T. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000401)86:1<15::aid-ijc3>3.0.co;2-b · Cited by 106
Brown, C. K., Modzelewski, R. A., Johnson, C. S., & Wong, M. K. K. (2000) · Annals of Surgical Oncology · doi:10.1007/s10434-000-0743-0 · Cited by 52
Cooke, S. P., Boxer, G., Lawrence, L., Pedley, R. B., Spencer, D. I. R., Beǵent, R. H. J., & Chester, K. A. (2001) · PubMed · Cited by 52
Dallabrida, S. M., Sousa, M. A. D., & Farrell, D. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001446200 · Cited by 36
Cited by
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Photodynamic therapy for cancer
Dolmans, D. E. J. G. J., Fukumura, D., & Jain, R. K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1071 · Cited by 6,758
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
The extracellular matrix: A dynamic niche in cancer progression
Lu, P., Weaver, V. M., & Werb, Z. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201102147 · Cited by 3,024
Metadata
- Authors
- Ruoslahti, E.
- Venue
- Nature Reviews Cancer
- Published
- 2002-02-01
- Volume
- 2
- Issue
- 2
- Pages
- 83-90
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1999600810
- Cited by
- 722
- References
- 78
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.